Accelerator Life Science Partners Mourns the Loss of Senior Advisor and Friend, Tadataka Tachi Yam pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Zymergen Purchases Lodo Therapeutics
Zymergen Inc. has acquired
Lodo Therapeutics Corp. from
Accelerator Life Science Partners, an early-stage life science accelerator and investment firm. The transaction is the third exit from ALSP’s investment fund,
Accelerator Life Science Partners I, in the last year.
Lodo Therapeutics discovered and developed novel therapeutics to address undruggable targets by applying its proprietary platform to tap the vast collections of undiscovered molecules encoded in environmental microbial DNA.
“The Lodo Therapeutics metagenomic platform complements Zymergen’s discovery efforts by expanding their natural product discovery capabilities,” said
Sean Brady, cofounder of Lodo Therapeutics. “I am grateful for the support that the ALSP team provided during Lodo’s development and am eager to incorporate our technology into Zymergen’s platform.”
Amgen acquires a small biotech and its inflammatory disease research biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Windtree Strengthens Its Board by Appointing Three New Directors
February 4, 2021 GMT
Windtree Therapeutics, Inc. - Striving to deliver hope for a lifetime
WARRINGTON, Pa., Feb. 4, 2021 /PRNewswire/ Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the appointments of Dr. Evan Loh, Ms. Leslie Williams, and Dr. Rob Scott, to its Board of Directors. The appointments are the result of a board composition analysis conducted by the Board, which took into consideration the changing needs of the Company. In connection with the appointments, Mr. John Leone, Mr. Joseph Mahady, and Dr. Brian Schreiber announced their retirement from the Board. Following the changes, the Windtree Board will continue to be comprised of seven directors.